logo
Select company
Select metric
6.02Cash Ratio
VS
Market
94
Sector
90
Industry
85
History
95
$ 2.2Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 11.08M6.02$ 1.84M
3/31/2025$ 4.68M2.54$ 1.84M
12/31/2024$ 3.42M1.91$ 1.79M
9/30/2024$ 5.58M3.89$ 1.44M
6/30/2024$ 6.57M3.33$ 1.97M
3/31/2024$ 7.6M4.97$ 1.53M
12/31/2023$ 9.53M5.67$ 1.68M
9/30/2023$ 6.74M5.03$ 1.34M
6/30/2023$ 8.91M4.45$ 2M
3/31/2023$ 9.6M4.23$ 2.27M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash Ratio stands at 2.4.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average Cash Ratio has been 3.96.
  • The median Cash Ratio for INMED PHARMACEUTICALS INC during this period was 4.06
  • INMED PHARMACEUTICALS INC reached its highest Cash Ratio over the past 5 years at 7.96.
  • The lowest Cash Ratio recorded by INMED PHARMACEUTICALS INC in the same timeframe 1.44

INMED PHARMACEUTICALS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
NBY : NOVABAY PHARMACEUTICALS INC 2.49XBIO : XENETIC BIOSCIENCES INC 5.29SPRB : SPRUCE BIOSCIENCES INC 2.03CPHI : CHINA PHARMA HOLDINGS INC 0.12ONCO : ONCONETIX INC 0.02SXTP : 60 DEGREES PHARMACEUTICALS INC 1.16BNBX : APPLIED DNA SCIENCES INC 2.69ADTX : ADITXT INC 0.03CDT : CONDUIT PHARMACEUTICALS INC 0.76GTBP : GT BIOPHARMA INC 2.31

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for INMED PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 4.5M ] / LiabilitesC [ $ 1.87M ]
(=) Cash Ratio [ 2.4 ]

INM - Cash Ratio, Last 5 years

1.44

Minimum

Mar 31, 2022

7.96

Maximum

Sep 30, 2021

3.96

Average

4.06

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63